Brief: Opana ER Antitrust Trial Concludes With Jury Verdict In Endo's Favor
01/07/2022 18:37
July 1 (Reuters) - Endo International PLC ENDP.O :
* OPANA® ER ANTITRUST TRIAL CONCLUDES WITH JURY VERDICT IN
ENDO'S
FAVOR
* ENDO INTERNATIONAL PLC - FEDERAL JURY IN CHICAGO RETURNED
A
VERDICT IN FAVOR OF COMPANY'S SUBSIDIARIES IN AN ANTITRUST TRIAL
Source text for Eikon: urn:newsml:reuters.com:*:nCNW2CmXHa
Further company coverage: ENDP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes